Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-09

Clinical Trial Update: Effect of Gefapixant on Cough-related Brain Activity in Patients With Chronic Cough [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial evaluating the effect of gefapixant on cough-related brain activity in patients with chronic cough; recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gefapixant (gefapixant)

Snippet

Sponsor: Stuart Mazzone | Conditions: Chronic Cough | EARLY_Phase 1 | Status: RECRUITING